The hormonal effects of tamoxifen (10 mg daily for 6 months) have been studied in nine men with oligospermia. Basal concentrations of serum LH (1\ m=. \ 7 \m=+-\ 0\ m=. \ 1 (s.e.m.) i.u./l) increased to a maximum of 4\ m=. \ 1 \ m=+-\ 1\ m=. \ 3 i.u./l (P < 0\m=.\001) after 6 months, and FSH rose from 4\ m=. \ 9 \ m=+-\1\m=.\0 to a maximum of 7\ m=. \ 7 \ m=+-\ 1\ m=. \ 3 i.u./l after 4 months of treatment (P < 0\m=.\01).
INTRODUCTION
Tamoxifen is a non-steroidal derivative of triphenylethylene which has been shown to possess anti-oestrogenic properties in some mammalian species (Harper & Walpole, 1966) ; it is chemically related to clomiphene. Clomiphene citrate stimulates gonadotrophin release by competing with oestrogen at hypothalamic receptor sites (Kato, Kobayashi & Villee, 1968) . Marshall, Anderson, Burke, Galvao-Teles & Fraser (1972) showed a rise in luteinizing hormone (LH), 17/î-hydroxyandrogens, and cortisol in the blood following administration of the drug to normal men; increases in testosterone and cortisol were associated with increases in their respective binding globulins.
Idiopathic oligospermia is a common cause of male infertility, and the aetiology of the disorder is obscure. Attempts have been made to treat oligospermia with human menopausal gonadotrophin (Lytton & Mroueh, 1966) , testosterone (Rowley & Heller, 1972) , and clomiphene citrate (Heller, Rowley & Heller, 1969; Foss, Tindall & Birkett, 1973) . Wieland, Ansari, Klein, Doshi, Hallberg & Chen (1972) treated 11 men with idiopathic oligospermia with a low dosage of clomiphene (5-10 mg daily) for 12 weeks. By week 12 of therapy there were significant increases in LH and testosterone, but rises in sperm counts occurred unpredictably. Despite inducing these hormonal changes clomiphene has generally proved to be an ineffective treatment for oligospermia.
Clomiphene consists of a mixture of isomers and has been shown to exhibit both antioestrogenic and oestrogenic effects (Czygan & Schulz, 1972) . The eis isomer has the proper¬ ties of an anti-oestrogen, and Reyes & Faiman (1974) reported increased sperm counts, serum LH, testosterone and oestradiol concentrations after long-term therapy in infertile men. Tamoxifen is the trans isomer of l-(/>-dimethylaminoethoxyphenyl)-l,2-diphenyl-2-ethylethylene, which in some species behaves essentially as an anti-oestrogen (Harper & Walpole, 1967 (Shaw, Butt, London & Marshall, 1974; Duignan, Shaw, Rudd, Holder, Williams, Butt, Logan Edwards & London, 1975) . Sex hormone binding globulin capacity (Rudd, Duignan & London, 1974) (Fig. 1 a) Tamoxifen produced a rise in mean basal FSH from 4-9 + 1-0 to 7-7 ± 1-3 i.u./l (P < 0-01) by week 16 of treatment (Fig. 1 b) . The increase in FSH occurred more slowly than for LH and dropped to pre-treatment concentrations within 1 month of stopping treatment. Gonadotrophin response to LH-RH The response is expressed as the sums of increments of serum LH at 30 and 60 min above the mean of the basal values. Treatment with tamoxifen produced increases in the sums of increments of LH from 35 ± 4 to 92 ± 16-6 i.u./l/60 min at 16 weeks (P < 0-001) (Fig. 2d) .
Tamoxifen therapy produced an increase in the sums of increments of FSH after LH-RH from 14 ±3-4 to a maximum of 23 + 3-5 i.u./l/60 min at 16 weeks (P < 0-01) (Fig. 2b) .
Steroid hormones
Before treatment basal serum androgen values were within the normal range of 10-40 nmol/1. Tamoxifen produced a rise in basal androgen values from 25 + 2-7 nmol/1 (Fig. 3 a) at the beginning of treatment to 38 + 2-4 nmol/1 (P < 0-05) after 16 weeks.
Before treatment basal serum oestradiol values were within our normal range for adult males of 80-250 pmol/1. Tamoxifen produced a rise in basal oestradiol (Fig. 3 b) from 185 ± 25 pmol/1 to a maximum of 631 +90 pmol/1 after 24 weeks (P < 0-001). The increase in oestradiol first became significant (P < 0-05) after treatment for 12 weeks. The rise in androgens and oestradiol in the blood is interpreted as being secondary to the increased levels of gonadotrophins. Increased testicular production probably accounts for most of the increase in steroid hormones, but some peripheral conversion of androgen to oestrogens may also occur (MacDonald, Rombaut & Siiteri, 1967) .
In the short-term control study, tamoxifen given for 7 days produced no change in basal serum LH or FSH, or in gonadotrophin response to LH-RH. However a significant rise in oestradiol and androgen in the circulation occurred, the mechanism of which is uncertain. It may be that tamoxifen produced transitory changes in gonadotrophin secretion too small to be detected in the two samples taken, but sufficient nevertheless to stimulate steroido¬ genesis. Alternatively, it might be speculated that tamoxifen stimulates the gonad directly, or alters its sensitivity to gonadotrophin, or that it has some effect on prolactin secretion.
The hormonal effects of tamoxifen in oligospermic men resemble those of clomiphene in that both compounds produce a rise in basal gonadotrophins and testosterone. In this investigation tamoxifen therapy enhanced the gonadotrophin response to LH-RH. There are no comparable data available on the long-term effects of clomiphene upon the LH-RH response in men. In a short-term study by Dhont, de Gezelle & Vandekerckhove (1976) , the pituitary responsiveness to LH-RH was reduced in normal men given clomiphene. However Hashimoto, Miyai, Matsumoto, Izumi & Kumahara (1975) showed that basal gonadotro¬ phins and testosterone in the circulation were raised in normal men treated with clomiphene, and in addition there was an enhancement of the FSH response to LH-RH. LH release was not however increased, possibly due to suppression by the increased testosterone concentra¬ tion.
Despite the hormonal changes induced by tamoxifen, no significant change in sperm counts was observed. It therefore appears that tamoxifen is an ineffective treatment for idiopathic oligospermia when given in a dosage of 10 mg daily for 6 months. More prolonged therapy with higher dosages may however be more effective in increasing sperm count (Comhaire, 1976) .
During the investigation one subject described two episodes of hot flushes ; none of the others experienced these, and no other side-effects of tamoxifen were noted.
